Salvia BioElectronics’ device is currently being tested in a blinded, sham-controlled study, with two paper-thin implants placed under the skin at the front and back of the head that deliver ...

Eindhoven, the Netherlands, May 27, 2025: Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, today announced the ...

Eindhoven, the Netherlands, May 27, 2025: Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, today announced the ...

In this article, we are going to take a look at where Bunge Global SA (NYSE:BG) stands against other best agriculture stocks to buy now. Tariff Crisis in the US Agricultural Sector On April 28 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

At a traditional Chinese medicine (TCM) planting base in Juancheng county in Shandong province, broad stretches of Salvia miltiorrhiza Bge plants unfold on Feb 20, as a gentle breeze blows, sending a ...

Salvia BioElectronics announced today that it completed a $60 million Series B financing round to support its migraine treatment. The funding enables the Dutch medtech company to complete the ...

The final, formatted version of the article will be published soon. 1) Background: Protocatechualdehyde (PCA), a phenolic compound derived from Salvia miltiorrhiza, exhibits anti-proliferative and ...

Bunge Limited Finance Corp. (BLFC) has extended the expiration date of its exchange offers and consent solicitations from April 7, 2025, to May 5, 2025. The offers aim to exchange outstanding notes ...